Dudediligence.

Acumen Pharmaceuticals, Inc

ABOSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 168-KRegulation FD disclosure7.019.01
  2. Aug 1210-QQuarterly report
  3. Aug 128-KResults of operations and Regulation FD disclosure2.027.019.01
  4. Jun 168-KRegulation FD disclosure and other events7.018.019.01
  5. Jun 38-KShareholder vote5.07
  6. May 1210-QQuarterly report
  7. May 128-KResults of operations and Regulation FD disclosure2.027.019.01
  8. Apr 1424B3Prospectus for an offering
  9. Mar 26S-3Shelf registration
  10. Mar 2610-KAnnual report
  11. Mar 268-KResults of operations and Regulation FD disclosure2.027.019.01
  12. Mar 168-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  13. Jan 128-KRegulation FD disclosure7.019.01
  14. Nov 13, 2025424B5Prospectus for an offering
  15. Nov 12, 202510-QQuarterly report
  16. Nov 12, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  17. Nov 10, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  18. Aug 12, 202510-QQuarterly report
  19. Aug 12, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  20. Jul 15, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  21. Jun 5, 20258-KShareholder vote5.07
  22. May 13, 202510-QQuarterly report
  23. May 13, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  24. Mar 27, 202510-KAnnual report
  25. Mar 27, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  26. Nov 12, 202410-QQuarterly report
  27. Nov 12, 20248-KResults of operations and Regulation FD disclosure2.027.019.01